The different types of multiple myeloma (MM ... amyloidosis (LCA), the atypical plasma cells make too many light chains, which then build up in the body’s tissues as an atypical protein called ...

Cesar Rodriguez, MD, discussed several key aspects of talquetamab use in the treatment of relapsed/refractory multiple ...

Multiple myeloma (MM) is cancer of the plasma cells ... and all can have side effects. That’s why it is so important to communicate with your doctor about how your body is responding to the ...

Multiple myeloma is a kind of blood cancer that starts in plasma cells. Inside most of your bones is a soft, spongy tissue called bone marrow. Here, your body makes hundreds of thousands of red ...

But the myeloma plasma cells make abnormal antibodies. This can make it hard for your body to fight infection ... You may get medicine for nausea and vomiting if you have these side effects. Eat ...

Background: Improvements in some treatment programs for multiple myeloma (MM) are increasing survival. As patients live longer with MM as a chronic disease, the personal financial effects of MM ...

The average age for a multiple myeloma diagnosis is 69 ... But young people can also develop the condition, in which the body’s plasma cells become cancerous and grow out of control.

Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

There may be a link to autoimmune diseases, genetics, or environmental factors. Like multiple myeloma, MGUS starts in a type of white blood cell called plasma cells. These cells make m-protein. This ...

In the future, the group plans on interrogating more precise molecular effects of GSI treatment on myeloma cells. This work was supported by a donation from Richard Lane and research funding from Juno ...

When delivered back to the patient’s body ... used in multiple myeloma treatment disrupt microtubules during mitosis. BMS is targeting the warhead directly to plasma cells to avoid the non ...